Hikma Pharmaceuticals PLC is a globally recognized pharmaceutical company specializing in the development, manufacturing, and commercialization of generic medicines. Established in 2005, Hikma operates as a leading player in the pharmaceutical industry, focusing primarily on providing affordable and accessible medicines worldwide. The company’s core business centers around the production of a broad portfolio of generic products across various therapeutic areas, including cardiovascular, central nervous system, and anti-infective medications. Hikma’s international presence is significant, with operations spanning across North America, Europe, and Asia-Pacific. The company’s strategic focus is on providing reliable and cost-effective solutions to address unmet medical needs. As a leading manufacturer, Hikma leverages advanced technologies and stringent quality control measures throughout its operations. The company’s SIC codes reflect its primary business activities – specifically, -21100: Manufacture of basic pharmaceutical products. Hikma is structured as a ‘type’ company, indicating a significant and growing presence within the pharmaceutical sector. The company is currently employing a workforce of leading professionals, and actively seeks to expand its global reach through strategic partnerships and acquisitions.

Hikma Pharmaceuticals PLC is a globally recognized pharmaceutical company specializing in the development, manufacturing, and commercialization of generic medicines. Established in 2005, Hikma operates as a leading player in the pharmaceutical industry, focusing primarily on providing affordable and accessible medicines worldwide. The company’s core business centers around the production of a broad portfolio of generic products across various therapeutic areas, including cardiovascular, central nervous system, and anti-infective medications. Hikma’s international presence is significant, with operations spanning across North America, Europe, and Asia-Pacific. The company’s strategic focus is on providing reliable and cost-effective solutions to address unmet medical needs. As a leading manufacturer, Hikma leverages advanced technologies and stringent quality control measures throughout its operations. The company’s SIC codes reflect its primary business activities – specifically, -21100: Manufacture of basic pharmaceutical products. Hikma is structured as a ‘type’ company, indicating a significant and growing presence within the pharmaceutical sector. The company is currently employing a workforce of leading professionals, and actively seeks to expand its global reach through strategic partnerships and acquisitions.